Why the study?
The consumption of mono- and polyunsaturated fatty acids may reduce clinical events related to atherosclerosis, prompting investigation into their effects on cardiovascular morphology and vascular reactivity in hypercholesterolemia.
Does supplementation with ω-3 PUFAs improve cardiovascular morphology and aortic vascular reactivity in adult male rats on a hypercholesterolemic diet?
Does supplementation with ω-3 PUFAs improve cardiovascular morphology and aortic vascular reactivity in adult male rats on a hypercholesterolemic diet?
In a rat model of hypercholesterolemia, ω-3 PUFA supplementation improved vascular endothelial function and preserved cardiovascular morphology without altering lipid profiles.
Supplementation effects in hypercholesterolemic rats should not change practice; leaves open translation to human atherosclerosis prevention.
Atherosclerosis is a cardiovascular disease associated with abnormalities of vascular functions. The consumption of mono- and polyunsaturated fatty acids can be considered a strategy to reduce clinical events related to atherosclerosis. In the present study, we investigated the effects of supplementation with 310 mg of ω-3 PUFAs (2:1 eicosapentaenoic/docosahexaenoic acids) for 56 days on rats with hypercholesterolemia induced by a diet containing cholesterol (0.1%), cholic acid (0.5%), and egg yolk. Serum biochemical parameters were determined by the enzymatic colorimetric method. Assessment of vascular effects was performed by analysis of histological sections of the heart and aortic arch stained with hematoxylin and eosin and vascular reactivity of the aorta artery. We observed that treatment with ω-3 PUFAs did not promote alterations in lipid profile. On the other hand, we documented a favorable reduction in liver biomarkers, as well as contributions to the preservation of heart and aortic arch morphologies. Interestingly, the vascular reactivity of rat thoracic aortic preparations was improved after treatment with ω-3 PUFAs, with a decrease in hyperreactivity to phenylephrine and increased vasorelaxation promoted by acetylcholine. Our findings suggest that the supplementation of hypercholesterolemic rats with ω-3 PUFAs promoted improvement in liver and vascular endothelial function as well as preserving heart and aortic tissue, reinforcing the early health benefits of ω-3 PUFAs in the development of atherosclerotic plaque and further related events.
No takes yet. Share an insight, caveat, or question.
Furtado et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: